Abstract:A dopamine derivative, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, known as salsolinol (SAL), has increasingly gained attention since its first detection in the urine of Parkinson's disease patients treated with levodopa, and has been proposed as a possible neurotoxic contributor to the disease. Yet, so far, the neurobiological role of SAL remains unclear. Thus, the main aims of our study were to compare the neurotoxic potential of SAL with MPP + (1-methyl-4-phenylpyridinium ion) in vitro, and to examine intestinal and metabolic alterations following intraperitoneal SAL administration in vivo. In vitro, SH-SY5Y neuroblastoma cell line was monitored following MPP + and SAL treatment. In vivo, Wistar rats were subjected to SAL administration by either osmotic intraperitoneal mini-pumps or a single intraperitoneal injection, and after two weeks, biochemical and morphological parameters were assessed. SH-SY5Y cells treated with MPP + (1000 μM) and SAL (50 μM) showed increase in cell viability and fluorescence intensity in comparison with the cells treated with MPP + alone. In vivo, we predominantly observed decreased collagen content in the submucosal layer, decreased neuronal density with comparable ganglionic area in the jejunal myenteric plexus, and increased glial S100 expression in both enteric plexuses, yet with no obvious signs of inflammation. Besides, glucose and triglycerides levels were lower after single SAL-treatment (200 mg/kg), and low- to high-density lipoprotein (LDL/HDL) ratio and aspartate to alanine aminotransferases (AST/ALT) ratio levels were higher after continuous SAL-treatment (200 mg/kg in total over 2 weeks). Low doses of SAL were non-toxic and exhibited pronounced neuroprotective properties against MPP + in SH-SY5Y cell line, which supports the use of SAL as a reference compound for in vitro studies. In vivo results give insight into our understanding of gastrointestinal remodeling following intraperitoneal SAL administration, and might represent morphological correlates of a microglial-related enteric neurodegeneration and dopaminergic dysregulation.

Sal Synthase Induced Cytotoxicity of PC12 Cells Through Production of the Dopamine Metabolites Salsolinol and N-methyl-salsolinol.

Existence and Characterization of Salsolinol Synthase in Neuronal Cells and Rat Brain

Characterization of salsolinol synthase from rat brain

Salsolinol, a Dopamine-derived Tetrahydroisoquinoline, Occur in Dopaminergic SH-SY5Y Cells Induced by Dopamine

S-adenosyl Methionine Enhance the Toxicity of Salsolinol in Dopaminergic SH-SY5Y Cell

Salsolinol Induces Parkinson's Disease Through Activating NLRP3-Dependent Pyroptosis and the Neuroprotective Effect of Acteoside

Neuroprotective effect of salidroside against 6-OHDA-induced oxidative stress in PC12 cells

Isolation and Sequencing of Salsolinol Synthase, an Enzyme Catalyzing Salsolinol Biosynthesis.

[Research Progress of Neurobiological Function of 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline].

Increased Vulnerability of Parkin Knock Down PC12 Cells to Hydrogen Peroxide Toxicity: the Role of Salsolinol and NM-salsolinol

Salsolinol as an RNA m6A methylation inducer mediates dopaminergic neuronal death by regulating YAP1 and autophagy

Effect Of (R)-Salsolinol And N-Methyl-(R)-Salsolinol On The Balance Impairment Between Dopamine And Acetylcholine In Rat Brain: Involvement In Pathogenesis Of Parkinson Disease

Enzymatic Condensation of Dopamine and Acetaldehyde: a Salsolinol Synthase from Rat Brain

Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.

Salsolinol Protects SH-SY5Y Cells Against MPP+ Damage and Increases Enteric S100-Immunoreactivity in Wistar Rats

The Formation of Catechol Isoquinolines in PC12 Cells Exposed to Manganese

Salsolinol Damaged Neuroblastoma SH-SY5Y Cells Induce Proliferation of Human Monocyte THP-1 Cells Through the mTOR Pathway in a Co-culture System

Salidroside protected against MPP + -induced Parkinson's disease in PC12 cells by inhibiting inflammation, oxidative stress and cell apoptosis.

Formation and Metabolism of Catecholamine Isoquinolines in the 6-OHDA Lesion rat Model Brains

Salsolinol—neurotoxic or Neuroprotective?

Determination of Endogenous Catecholamine Isoquinolines in α-Synuclein Transgenic Mice by HPLC-MS/MS